Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Hemodynamic Protection in C-Section
NCT04140058Phase 3Completed
- Sponsor
- University of Jordan
- Start
- Jan 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ondansetron in hypotension, nausea ((none)) and Vomiting (3 arms), sponsored by University of Jordan. Primary endpoints: Systolic Blood Pressure, Diastolic Blood Pressure and 1 more. Started Jan 2016; status: completed.
02
Drugs
ondansetron
03
Conditions
hypotensionnausea ((none))Vomiting
Beyond the preview
Go deeper on NCT04140058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04140058.